Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Inclusion Criteria: * Participant able to provide written informed consent * Participant is 18 to 65-years old * Participant has confirmed opioid use disorder (OUD) as defined by the Diagnostic and Statistical Manual of Mental Disorders-5 * Participants is entering an OUD treatment program Exclusion Criteria: * Participant requires tapering from another substance at entry to treatment * Participant is pregnant or lactating * Participant has a history of hemophilia or psoriasis vulgaris * Participant has a cardiac pacemaker implant device * Participant has irritated or broken skin at the site of intended device placement * Participant is currently participating in, or was enrolled in another clinical trial within the last 30 days * Participant has a history of poor wound healing * Participant has a severe autoimmune disease or uncontrolled diabetes * Participant has an open wound/abscess infection/MRSA * Participant has a history of a chronic pain in the last 90 days * Participant has a serious medical condition which in the judgment of the principal investigator or his/her designee would make study participation unsafe, or would make intervention compliance difficult * Participant has a psychiatric illness (bipolar disorder, schizophrenia, or other psychotic disorder, active suicidal ideation with a plan within the last month or suicide attempt)